You are here: Industry Insights > competition

News List

The Curtain Has Risen on the Competition for the First Generic Drug, so What Other Innovative Drugs in the Rare Disease Field Can We Look Forward to? Xiaobin
January 23, 2025
The CDE website shows Qilu Pharmaceutical applied for the marketing of nusinersen generic. Once controversial for high price, it treats SMA. Now many firms are involved, and SMA treatment progresses.
Next Stop for PD-1? MNC for Subcutaneous Preparation Takes the Lead in Competition, Leading to A More Fierce Domestic Conpetition, but Differentiation is not easy Spur 203/PharmaSources
December 14, 2023
The competition for the subcutaneous formulation of PD-1/PD-L1 inhibitors has been spreading globally for a long time, with Roche and Bristol Myers Squibb currently leading the pack.
With the BGB-16673 Clinical Trials of BeiGene Launched, PROTAC Leads a Brand New Trend of Global Competition PharmaSources/Wanghong
March 21, 2022
On February 28, BGB-16673, a BTK-targeted PROTAC drug of BeiGene, was launched for clinical trials for the first time in China.
Fierce Competition of R&D of KRAS G12C Inhibitors PharmaSources/Yi
January 13, 2022
Recently, the class 1 new drug "ZG19018 Tablets" of Suzhou Zelgen Biopharmaceuticals Co., Ltd. is approved for clinical use in China and the indications are: advanced malignant solid tumors with KRAS G12C mutation.
FDA issues series of guidances under Drug Competition Action Plan FDA
January 28, 2022
This week, FDA published a series of guidances focused on generic drug application submissions, labeling, and review. These guidances are part of our continued efforts to bring greater efficiency and transparency to the generic drug review process...
Ping An's AI-driven AskBob Doctor Earns Top Scores in Diabetes Management Competition prnasia
December 08, 2021
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that its AskBob Doctor, an artificial intelligence-driven consultation and treatment assistance tool...
Ascensia Diabetes Care Announce Winner of This is Diabetes Art and Photo Competition prnasia
November 15, 2021
Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributors of the Eversense® continuous glucose monitoring (CGM)...
Ascensia Diabetes Care Launches the "This is Diabetes" Competition to Highlight the Need for Access to Diabetes Care in Support of IDF's World Diabetes Day prnasia
October 13, 2021
Today Ascensia Diabetes Care, makers of the CONTOUR® Blood Glucose Monitoring system portfolio and distributors of the Eversense® Continuous Glucose Monitoring system, has launched its "This is Diabetes" art...
Competition and Markets Authority investigating AstraZeneca’s Alexion acquisition europeanpharmaceuticalreview
May 31, 2021
The UK’s competition authority will assess whether AstraZeneca’s acquisition of Alexion will result in a “substantial lessening of competition”.
hIVIG is good COVID-19 treatment option but faces competition from convalescent plasma expresspharma
November 02, 2020
Unlike convalescent plasma, hIVIG is a plasma product that is a standardised and concentrated mixture of polyclonal antibodies against the SARS-CoV-2.